clopidogrel
Ligand Summary
A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
UNII: A74586SNO7
PubChem: 60606
ChEMBL: CHEMBL1771
DrugCentral: 708
LyCHI: A2KHQ3U645YJ
Target Activities
5 Activities
Items per page:
10
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
Ki | ANTAGONIST | |||||